1. Home
  2. RANI vs DH Comparison

RANI vs DH Comparison

Compare RANI & DH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

HOLD

Current Price

$0.82

Market Cap

126.8M

Sector

Health Care

ML Signal

HOLD

Logo Definitive Healthcare Corp.

DH

Definitive Healthcare Corp.

HOLD

Current Price

$1.06

Market Cap

116.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
RANI
DH
Founded
2012
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
126.8M
116.0M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
RANI
DH
Price
$0.82
$1.06
Analyst Decision
Strong Buy
Hold
Analyst Count
4
5
Target Price
$8.50
$3.43
AVG Volume (30 Days)
983.3K
360.5K
Earning Date
03-26-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
57.14
63.28
EPS
N/A
N/A
Revenue
$1,633,000.00
$241,521,000.00
Revenue This Year
$321.62
N/A
Revenue Next Year
$74.26
$0.30
P/E Ratio
N/A
N/A
Revenue Growth
58.85
N/A
52 Week Low
$0.39
$0.97
52 Week High
$3.87
$4.70

Technical Indicators

Market Signals
Indicator
RANI
DH
Relative Strength Index (RSI) 23.41 32.44
Support Level $0.46 $0.97
Resistance Level $0.87 $1.29
Average True Range (ATR) 0.09 0.08
MACD -0.04 0.03
Stochastic Oscillator 0.02 24.36

Price Performance

Historical Comparison
RANI
DH

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

About DH Definitive Healthcare Corp.

Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: